Abu Dhabi’s ADSCC performs ‘region’s first stem cell transplant’

Abu Dhabi’s ADSCC performs ‘region’s first stem cell transplant’

UAE - Doctors at Abu Dhabi Stem Cells Centre (ADSCC), part of PureHealth Group, have performed the region’s first successful bone marrow transplant on a patient suffering from Multiple Sclerosis (MS).

The significant achievement in bone marrow transplantation, performed under the Abu Dhabi Bone Marrow Transplant (AD-BMT) programme, demonstrates a major advance in cell therapy and regenerative medicine capabilities to treat a range of diseases, including cancer and immune disorders.

Doctors at ADSCC performed the region’s first autologous hematopoietic stem cell transplantation (AHSCT) on a patient with MS earlier this month and the patient has since reported an improvement in her overall condition. The treatment, developed by the ADSCC, aims to ‘reset’ a person’s immune system and can be used for those with relapsing forms of MS.

Supporting Covid-19 patients

The transplant success follows ADSCC’s ground-breaking work supporting Covid-19 patients during the pandemic, for which the centre was commended by Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO), for its cutting-edge Covid-19 treatments. These included UAECell19, which ADSCC launched in 2020 and was used to treat thousands of Covid-19 patients, helping to regenerate lung capacity through stem cell therapy.

Established in 2020, ADSCC’s Abu Dhabi Bone Marrow Transplant (AD-BMT) programme was designed